Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications from the Centre for Immuno-Oncology

Peptide-specific natural killer cell receptors.

Journal article

Sim MJW. et al, (2025), Oxf Open Immunol, 6

TCRs and AI: the future is now.

Journal article

Sim MJW., (2023), Nat Rev Immunol

High-affinity oligoclonal TCRs define effective adoptive T cell therapy targeting mutant KRAS-G12D.

Journal article

Sim MJW. et al, (2020), Proceedings of the National Academy of Sciences of the United States of America, 117, 12826 - 12835

Human NK cell receptor KIR2DS4 detects a conserved bacterial epitope presented by HLA-C.

Journal article

Sim MJW. et al, (2019), Proceedings of the National Academy of Sciences of the United States of America, 116, 12964 - 12973

Lung Defense through IL-8 Carries a Cost of Chronic Lung Remodeling and Impaired Function.

Journal article

Reynolds CJ. et al, (2018), American journal of respiratory cell and molecular biology, 59, 557 - 571

HLA-F: A New Kid Licensed for Peptide Presentation.

Journal article

Sim MJW. and Sun PD., (2017), Immunity, 46, 972 - 974

KIR2DL3 and KIR2DL1 show similar impact on licensing of human NK cells.

Journal article

Sim MJW. et al, (2016), European journal of immunology, 46, 185 - 191

Load More